Atlas Trials

An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Clinical trial NCT01895452 · COMPLETED

Trial details

NCT number
NCT01895452
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2013-07-01
Primary completion
2016-06-01
Enrollment
291

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.